Natural Human Heparin Cofactor II protein (ab62249)

Overview

Description

  • Nature
    Native
  • Source
    Native
  • Amino Acid Sequence
    • Species
      Human

Specifications

Our Abpromise guarantee covers the use of ab62249 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    SDS-PAGE

    Functional Studies

  • Form
    Liquid
  • Additional notes
    Concentartion varies from lot to lot but is between 5-10mg/ml
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Preservative: None
    Constituents: 50% Glycerol

General Info

  • Alternative names
    • D22S673
    • HC II
    • HC-II
    • HC2
    • HCF2
    • HEP2_HUMAN
    • Heparin cofactor 2
    • Heparin cofactor II
    • HLS2
    • Leuserpin 2
    • LS2
    • Protease inhibitor leuserpin 2
    • Protease inhibitor leuserpin-2
    • serine (or cysteine) proteinase inhibitor, clade D (heparin cofactor), member 1
    • Serpin D1
    • serpin peptidase inhibitor, clade D (heparin cofactor), member 1
    • SERPIND1
    • THPH10
    see all
  • Function
    Thrombin inhibitor activated by the glycosaminoglycans, heparin or dermatan sulfate. In the presence of the latter, HC-II becomes the predominant thrombin inhibitor in place of antithrombin III (AT-III). Also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner.
    Peptides at the N-terminal of HC-II have chemotactic activity for both monocytes and neutrophils.
  • Tissue specificity
    Expressed predominantly in liver. Also present in plasma.
  • Involvement in disease
    Thrombophilia due to heparin cofactor 2 deficiency
  • Sequence similarities
    Belongs to the serpin family.
  • Domain
    The N-terminal acidic repeat region mediates, in part, the glycosaminoglycan-accelerated thrombin inhibition.
  • Post-translational
    modifications
    Phosphorylation sites are present in the extracellular medium.
  • Information by UniProt

References

ab62249 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab62249.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up